[Characteristics of liver damage in children with mucoviscidosis].

S. V. Rachinskiĭ,I. Potapova,N. Kapranov,O. Smirnova,I. V. Dvoriakovskiĭ

1981-11-01

Abstract:

What problem does this paper attempt to address?

Recurrent alcohol-associated hepatitis is common and is associated with increased mortality

Jordi Gratacós-Ginès,Pilar Ruz-Zafra,Miriam Celada-Sendino,Aina Martí-Carretero,Clàudia Pujol,Rosa Martín-Mateos,Víctor Echavarría,Luis E Frisancho,Sonia García,Mónica Barreales,Javier Tejedor-Tejada,Sergio Vázquez-Rodríguez,Nuria Cañete,Carlos Fernández-Carrillo,María Valenzuela,David Martí-Aguado,Diana Horta,Marta Quiñones,Vanesa Bernal-Monterde,Silvia Acosta,Tomás Artaza,José Pinazo,Carmen Villar-Lucas,Ana Clemente-Sánchez,Ester Badia-Aranda,Álvaro Giráldez-Gallego,Manuel Rodríguez,Pau Sancho-Bru,Joaquín Cabezas,Meritxell Ventura-Cots,Conrado Fernández-Rodríguez,Victoria Aguilera,Santiago Tomé,Ramon Bataller,Juan Caballería,Elisa Pose,Luis E. Frisancho,

DOI: https://doi.org/10.1097/hep.0000000000000825

IF: 17.298

2024-03-05

Hepatology

Abstract:Background: Alcohol relapse after surviving an episode of alcohol-associated hepatitis (AH) is common. However, the clinical features, risk factors and prognostic implications of recurrent AH (RAH) are not well described. Methods: A registry-based study of patients admitted to 28 Spanish hospitals for an episode of AH between 2014 and 2021. Baseline demographics and laboratory variables were collected. Risk factors for RAH were investigated using Cox regression analysis. We analyzed the severity of the index episodes of AH and compared it to that of RAH. Long-term survival was assessed by Kaplan-Meier curves and log-rank test. Results: A total of 1,118 patients were included in the analysis, 125 (11%) of whom developed RAH during follow-up (median: 17 [7-36] months). The incidence of RAH in patients resuming alcohol use was 22%. Median time to recurrence was 14 (8-29) months. Patients with RAH had more psychiatric comorbidities. Risk factors for developing RAH included age 10 units/day and history of liver decompensation. RAH was clinically more severe compared to first AH (higher MELD, more frequent ACLF and hepatic encephalopathy). Moreover, alcohol abstinence during follow-up was less common after RAH (18% vs 45%, p <0.001). Most importantly, long-term mortality was higher in patients who developed RAH (39% vs 21%, p =0.026) and presenting with RAH independently predicted high mortality (HR 1.55 [1.11-2.18]). Conclusions: RAH is common and has a more aggressive clinical course, including increased mortality. Patients surviving an episode of AH should undergo intense alcohol use disorder therapy to prevent RAH.

gastroenterology & hepatology
[Internet application for medical purposes in chronic patients cared in a systemic autoimmune diseases unit].

N. Ortego Centeno,J. C. Callejas Rubio,M. N. Benticuaga Martínez,F. Navarro Pelayo,J. de la Higuera Torres-Puchol

Abstract:OBJECTIVE In recent years Internet has become an important tool for medical information search, not only for physicians but also for the patients. Little is known about Internet patient's use in Spain. Our objective was to study the frequency with which patients with different chronic autoimmune diseases cared in our unit use Internet as a source of medical information, and to identify the factors associated with its use. METHODS A survey was carried out on Internet use to patients cared in a teaching hospital Systemic Autoimmune Diseases unit along three consecutive weeks. RESULTS Hundred thirty-eight patients completed the questionnaire. Eighty-seven (63%) were women. Fifty-four patients (39.1%) were older than 55 years. Mean disease progression was 34.2 +/- 39.2 months. 22% of the respondents were uneducated, 39% had elementary education level; 20% had average education level, and 20% had advanced education level. Forty-two patients (30.4%) used regularly Internet for any purpose. Factors associated to Internet use for medical purposes were regular Internet use (OR: 4.6; CI: 1.1-18.8;p = 0.03), and average or advanced educational degree (advanced education: OR: 22.9; CI: 2.6-202.7; p = 0.005; average education: OR: 8.5; CI: 1.2-59.6; p = 0.03). Eighty-one patients (58.7%) expressed their need of information on quality web pages. CONCLUSIONS Many patients use Internet for medical purposes in our environment and even more consider to use it in the future. It is important to be aware of this fact and facilitate information about quality web pages for interested patients.
Trauma is a recurrent disease.

Galen V. Poole,John A. Griswold,V. K. Thaggard,Robert S. Rhodes

DOI: https://doi.org/10.5555/URI:PII:003960609390349I

IF: 4.348

1993-06-01

Surgery

Abstract:BACKGROUND Many victims of trauma have a history of repetitive accidental or violent injuries, which implies that trauma is not necessarily a random event. Recurrent trauma is thought to be a problem of urban areas, associated with criminal activities, but there are few data from rural areas that include the victims of nonintentional injuries. METHODS The prior trauma experience of 200 consecutive patients admitted for trauma was compared with that of 100 consecutive emergency nontrauma surgical admissions and 100 elective surgical admissions to a university hospital and level I trauma center. RESULTS Trauma patients were younger than emergency patients and elective surgery patients. They were more likely to be male than either emergency or elective surgery patients and, along with emergency nontrauma patients, were more likely to be from a racial minority than were elective admissions. Trauma patients were more likely to have had a previous hospitalization for an injury than either emergency patients or elective surgery patients, and a greater proportion of their prior trauma admissions had been within the past 5 years than in the other two groups. There was no difference in the probability of a prior trauma admission between patients admitted with an intentional injury or an accidental injury, but patients whose current admission was for an intentional injury were three times more likely to have had a prior hospitalization as a result of an intentional injury than were patients admitted because of an accidental injury. CONCLUSIONS Trauma is a disease with a high risk of recurrence. This may be related to chronic high-risk behaviors such as alcohol or drug abuse, preexisting psychopathology, and cultural acceptance of violent resolution of personal conflicts, all of which adversely affect patients' lives. The role of intensive preventive measures after an initial injury, and directed toward specific high-risk behavior, should be evaluated.
P-19 CHARACTERIZATION, PROGNOSTIC FACTORS, AND SURVIVAL IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS: A MULTICENTER STUDY

Francisco Idalsoaga,Luis Antonio Díaz,Oscar Corsi,Gustavo Ayares,Jorge Arnold,Winston Dunn,Yanming Li,Ashwani Singal,Doug Simonetto,María Ayala-Valverde,Carolina A. Ramirez,Dalia Morales-Arraez,Wei Zhang,Steve Qian,Joseph Ahn,Seth Buryska,Heer Mehta,Muhammad Waleed,Horia Stefanescu,Adelina Horhat,Andreea Bumbu,Bashar Attar,Rohit Agrawal,Joaquín Cabezas,Berta Cuyàs,Maria Poca,German Soriano Pastor,Shiv K Sarin,Rakhi Maiwall,Prasun K Jalal,María Fátima Higuera-De La Tijera,Anand Kulkarni,Nagaraja Rao,Patricia Guerra Salazar,Lubomir Skladaný,Natália Bystrianska,Veronica Prado,Ana Clemente-Sanchez,Diego Rincón,Tehseen Haider,Kristina R Chacko,Gustavo A Romero,Florencia D Pollarsky,Juan Carlos Restrepo,Luis G Toro,Pamela Yaquich,Manuel Mendizabal,Maria Laura Garrido,Sebastian Marciano,Melisa Dirchwolf,Victor Vargas,Cesar Jimenez,Guadalupe García-Tsao,Guillermo Ortiz,Juan G Abraldes,Patrick Kamath,Vijay Shah,Ramon Bataller,Juan Pablo Arab

DOI: https://doi.org/10.1016/j.aohep.2023.101206

IF: 3.388

2024-02-01

Annals of Hepatology

Abstract:Introduction and Objectives Alcohol-associated hepatitis (AH) corresponds to a severe entity with high short-term mortality; however, few studies have been published in patients with moderate AH. This study aimed to characterize patients with moderate AH in a global study, identifying prognostic factors and survival at 30, 90, and 180 days. Materials and Methods Multi-center retrospective cohort study, which included patients with moderate AH (2009-2019). Moderate AH was defined as MELD 20 at presentation. We used competing-risk models with liver transplantation as a competing risk to assess variables associated with mortality. Results We included 564 patients (24 centers, 12 countries). Median age was 48±11.6 years, 29.2% female, and 46.2.5% Caucasian. 51.7% had cirrhosis, and 1.4% underwent liver transplantation. The MELD score on admission was 17 [6-20]. In the entire cohort, 37.7% used corticosteroids. Survival rates at 30, 90, and 180 days were 93.7% (0.911–0.955), 89.1% (0.860–0.916), and 87% (0.836–0.898), respectively. The most frequent causes of death were multiple organ failure (30.4%) and infections (11.5%). In the univariate analysis, variables associated with mortality were age (sHR 1.035, 95%CI:1.020–1.049; p <0.001), Maddrey's discriminant function (sHR 1.013, 95%CI:1.007–1.020; p<0.001), albumin at admission (sHR 0.837, 95%CI:0.682–1.026; p 0.087), INR (sHR 1.534; 95%CI: 1.070–2.198, p=0.020), renal replacement therapy (RRT) (sHR 7.066; 95%CI:4.381–11.392; p<0.001) and infections during hospitalization (sHR 2.079; 95%CI:1.308–3.306; p=0.002)(Table). However, in the multivariate-adjusted model, only age (sHR 1.042; 95%CI:1.019–1.0656, p<0.001), RRT (sHR 7.796; 95%CI:3.993–15.218, p<0.001) and infections during hospitalization (sHR 1.666; 95%CI:0.999–2.779; p=0.050) were associated with mortality. Of note, corticosteroids did not demonstrate benefit. Conclusions Patients with moderate AH have a significant mortality at short-term. Infections are associated with higher mortality and are the most important cause of death in these patients. Better models are necessary to predict mortality in moderate AH adequately.

gastroenterology & hepatology
The Survival Benefit of Re-abstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multi-Center ACCELERATE Study

Matthew Dukewich,Jennifer L Dodge,Michael R Lucey,John P Rice,Kirti Shetty,Neha Jakhete,Gene Y Im,Ethan M Weinberg,Christine Hsu,Coleman Smith,R Mark Ghobrial,George Therapondos,Mohamed Shoreibah,Mahmoud Aryan,Sheila Eswaran,Oren K. Fix,Haripriya Maddur,Norah Terrault,Brian P Lee

DOI: https://doi.org/10.14309/ajg.0000000000002956

2024-07-14

The American Journal of Gastroenterology

Abstract:Background and Aims: Early (i.e. without mandated period of abstinence) liver transplant (LT) for alcohol-associated hepatitis (AH) is the fastest growing indication for LT in the US and Europe. Harmful alcohol use post-LT is associated with poor outcomes but the distinction of establishing abstinence after return to drinking (i.e. re-abstinence) is understudied. This study aims to characterize the survival outcomes of achieving re-abstinence after post-LT harmful alcohol use. Methods: We analyzed early LT recipients from 12 US LT centers between 2006-2021. Post-LT alcohol use was characterized as harmful using criteria of "binge" (>5 [men] or >4 [women] drinks in 4 days in one week) by interview or phosphatidylethanol >20ng/mL. Re-abstinence was defined as >12 consecutive months without harmful alcohol use following harmful alcohol use. Results: Among 347 LT recipients (64% male, median age 43, median MELD-Na 38) with median post-LT follow-up of 2.2 years (IQI 1.1 – 3.6), 276 (80%) recipients had no evidence of harmful alcohol use, 35 (10%) recipients had re-abstinence, and 36 (10%) recipients had continued harmful alcohol use without re-abstinence. Five-year predicted survival, adjusted for age, sex, MELD-Na score, was lowest among LT recipients with continued harmful alcohol use (77%), but similar among those with no harmful use (93%) and re-abstinence (94%). Conclusions: Achieving re-abstinence after post-LT harmful alcohol use is associated with similar five-year post-LT survival compared to those without evidence of post-LT harmful alcohol use. Our findings highlight the importance of early detection and treatment of post-LT alcohol use.

gastroenterology & hepatology
Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium

Ann T Ma,Andrew S Allegretti,Giuseppe Cullaro,Tianqui Ouyang,Sumeet K Asrani,Raymond T Chung,Eric M Przybyszewski,Robert M Wilechansky,Jevon E Robinson,Pratima Sharma,Douglas A Simonetto,Prasun Jalal,Eric S Orman,Hani M Wadei,Shelsea A St Hillien,Danielle Saly,Nneka N Ufere,Leigh Anne Dageforde,Kevin R Regner,Justin M Belcher,Kavish R Patidar,from the HRS Harmony Consortium

DOI: https://doi.org/10.1111/apt.18159

Abstract:Background & aims: The development of acute kidney injury (AKI) in the setting of alcohol-associated hepatitis (AH) portends a poor prognosis. Whether the presence of AH itself drives worse outcomes in patients with cirrhosis and AKI is unknown. Methods: Retrospective cohort study of 11 hospital networks of consecutive adult patients admitted in 2019 with cirrhosis and AKI. AKI phenotypes, clinical course, and outcomes were compared between AH and non-AH groups. Results: A total of 2062 patients were included, of which 303 (15%) had AH, as defined by National Institute on Alcohol Abuse and Alcoholism (NIAAA) criteria. Patients with AH, compared to those without, were younger and had higher Model for End-stage Liver Disease-Sodium (MELD-Na) scores on admission. AKI phenotypes significantly differed between groups (p < 0.001) with acute tubular necrosis occurring more frequently in patients with AH. Patients with AH reached more severe peak AKI stage, required more renal replacement therapy, and had higher 90-day cumulative incidence of death (45% [95% CI: 39%-51%] vs. 38% [95% CI: 35%-40%], p = 0.026). Using no AH as reference, the unadjusted sHR for 90-day mortality was higher for AH (sHR: 1.24 [95% CI: 1.03-1.50], p = 0.024), but was not significant when adjusting for MELD-Na, age and sex. However, in patients with hepatorenal syndrome, AH was an independent predictor of 90-day mortality (sHR: 1.82 [95% CI: 1.16-2.86], p = 0.009). Conclusions: Hospitalised patients with cirrhosis and AKI presenting with AH had higher 90-day mortality than those without AH, but this may have been driven by higher MELD-Na rather than AH itself. However, in patients with hepatorenal syndrome, AH was an independent predictor of mortality.
Declining Inpatient Mortality Despite Increasing Thirty-Day Readmissions of Alcoholic Hepatitis in the United States From 2010 to 2018

Dushyant Singh Dahiya,Asim Kichloo,Jagmeet Singh,Gurdeep Singh,Farah Wani,Hafeez Shaka

DOI: https://doi.org/10.14740/gr1473

Abstract:Background: Alcoholic hepatitis (AH) readmissions are commonly secondary to relapse to alcohol use after discharge from the hospital. Methods: This retrospective interrupted trend study analyzed the National Readmissions Database (NRD) from 2010 to 2018 to identify 30-day readmissions of AH using the International Classification of Diseases (ICD)-9 and ICD-10 codes (571.1 and K70.1). Individuals < 18 years, elective and traumatic readmissions were excluded. The biodemographic characteristics and hospitalization trends were highlighted over an 8-year time frame. A multivariate regression analysis was used to calculate the risk-adjusted odds of trends for all-cause 30-day readmissions, AH-specific readmissions, inpatient mortality, mean length of stay (LOS), and mean total hospital charge (THC) after adjusting for age, gender, grouped Charlson Comorbidity Index (CCI), type of insurance, mean household income, and hospital characteristics. P-values ≤ 0.05 were considered statistically significant. Results: We noted an increasing trend for total 30-day readmissions of AH from 1,839 in 2010 to 3,784 in 2018 (P-trend < 0.001). Males made up a majority of the population; however, gender distribution was not statistically significant. Additionally, 30-day AH readmissions had an increasing comorbidity burden with time. The 30-day all-cause readmission rate increased from 18.8% in 2010 to 24.4% in 2018 and AH-specific readmission rate from 2.9% in 2010 to 3.9% in 2018 without a statistically significant trend. However, we noted a declining risk-adjusted trend of inpatient mortality for 30-day readmissions of AH from 8.7% in 2010 to 7.4% in 2018 (P-trend = 0.022). Furthermore, the total LOS attributable to 30-day readmissions of AH increased by 132.5% from 11,275 days in 2010 to 26,220 days in 2018 and the attributable THC increased by 160.9% to over $67 million in 2018. Conclusions: For 30-day AH readmissions, inpatient mortality declined to 7.4% in 2018, while the total number of hospitalizations, LOS and THC increased from 2010 to 2018.
Emerging Pharmacotherapies in Alcohol-Associated Hepatitis

Ali Wakil,Mumtaz Niazi,Mohamad A Meybodi,Nikolaos T Pyrsopoulos

DOI: https://doi.org/10.1016/j.jceh.2022.06.012

Abstract:The incidence of alcoholic-associated hepatitis (AH) is increasing. The treatment options for severe AH (sAH) are scarce and limited to corticosteroid therapy which showed limited mortality benefit in short-term use only. Therefore, there is a dire need for developing safe and effective therapies for patients with sAH and to improve their high mortality rates.This review article focuses on the current novel therapeutics targeting various mechanisms in the pathogenesis of alcohol-related hepatitis. Anti-inflammatory agents such as IL-1 inhibitor, Pan-caspase inhibitor, Apoptosis signal-regulating kinase-1, and CCL2 inhibitors are under investigation. Other group of agents include gut-liver axis modulators, hepatic regeneration, antioxidants, and Epigenic modulators. We describe the ongoing clinical trials of some of the new agents for alcohol-related hepatitis. Conclusion: A combination of therapies was investigated, possibly providing a synergistic effect of drugs with different mechanisms. Multiple clinical trials of novel therapies in AH remain ongoing. Their result could potentially make a difference in the clinical course of the disease. DUR-928 and granulocyte colony-stimulating factor had promising results and further trials are ongoing to evaluate their efficacy in the large patient sample.
Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis

Christine C Hsu,Jennifer L Dodge,Ethan Weinberg,Gene Im,Jimin Ko,William Davis,Stephanie Rutledge,Matthew Dukewich,Mohamed Shoreibah,Mahmoud Aryan,Aidan Vosooghi,Michael Lucey,John Rice,Norah A Terrault,Brian P Lee

DOI: https://doi.org/10.1097/HEP.0000000000000267

IF: 17.298

2023-04-01

Hepatology

Abstract:Background: Early liver transplantation for alcohol-associated hepatitis is controversial in part because patients may recover, and obviate the need for liver transplantation. Methods: In this retrospective study among 5 ACCELERATE-AH sites, we randomly sampled patients evaluated and then declined for liver transplantation for alcohol-associated hepatitis. All had Model of End-Stage Liver Disease (MELD) >20 and <6 months of abstinence. Recompensation was defined as MELD <15 without variceal bleeding, ascites, or overt HE requiring treatment. Multilevel mixed effects linear regression was used to calculate probabilities of recompensation; multivariable Cox regression was used for mortality analyses. Results: Among 145 patients [61% men; median abstinence time and MELD-Na was 33 days (interquartile range: 13-70) and 31 (interquartile range: 26-36), respectively], 56% were declined for psychosocial reasons. Probability of 30-day, 90-day, 6-month, and 1-year survival were 76% (95% CI, 68%-82%), 59% (95% CI, 50%-66%), 49% (95% CI, 40%-57%), and 46% (95% CI, 37%-55%), respectively. Probability of 1-year recompensation was low at 10.0% (95% CI, 4.5%-15.4%). Among patients declined because of clinical improvement, 1-year probability of recompensation was 28.0% (95% CI, 5.7%-50.3%). Among survivors, median MELD-Na at 30 days, 90 days, and 1-year were 29 (interquartile range: 22-38), 19 (interquartile range : 14-29), and 11 (interquartile range : 7-17). Increased MELD-Na (adjusted HR: 1.13, p <0.001) and age (adjusted HR: 1.03, p <0.001) were associated with early (≤90 d) death, and only history of failed alcohol rehabilitation (adjusted HR: 1.76, p =0.02) was associated with late death. Conclusions: Liver recompensation is infrequent among severe alcohol-associated hepatitis patients declined for liver transplantation. Higher MELD-Na and age were associated with short-term mortality, whereas only history of failed alcohol rehabilitation was associated with long-term mortality. The distinction between survival and liver recompensation merits further attention.
Racial Disparities in Alcoholic Hepatitis Hospitalizations in the United States: Trends, Outcomes, and Future Projections

Chun-Wei Pan,Daniel Guifarro,Ayusha Poudel,Yazan Abboud,Vikram Kotwal

DOI: https://doi.org/10.1007/s10620-024-08462-1

2024-05-31

Digestive Diseases and Sciences

Abstract:Alcoholic hepatitis (AH) is a serious complication of alcohol consumption with high morbidity and mortality, particularly in the United States where alcohol-related liver diseases rank as one of the leading causes of preventable death. Our study aims to analyze the morbidity and mortality of AH across racial groups and project hospitalization trends up to 2028, thereby informing public health initiatives.

gastroenterology & hepatology
Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis: Systematic review and meta‐analysis

Wen Hui Lim,Phoebe Tay,Cheng Han Ng,Darren Jun Hao Tan,Christen Ong,Jia Hong Koh,Margaret Teng,Douglas Chee,Zhen Yu Wong,Takumi Kawaguchi,Hirokazu Takahashi,Mark Muthiah,Eunice X. X. Tan,Karn Wijarnpreecha,Guan Huei Lee,Mazen Noureddin,Brian P. Lee,Philippe Mathurin,Rohit Loomba,Daniel Q. Huang

DOI: https://doi.org/10.1111/apt.17888

IF: 9.524

2024-02-03

Alimentary Pharmacology & Therapeutics

Abstract:Overview on prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis. Summary Background Although alcohol abstinence may be an effective intervention for alcohol‐associated cirrhosis, its association with prognosis has not been systematically assessed or quantified. Aims To determine the prevalence of alcohol abstinence, factors associated with alcohol abstinence and the impact of abstinence on morbidity and overall survival in people with alcohol‐associated cirrhosis. Methods We searched Medline and Embase from inception to 15 April 2023 for prospective and retrospective cohort studies describing alcohol abstinence in people with known alcohol‐associated cirrhosis. Meta‐analysis of proportions for pooled estimates was performed. The method of inverse variance, employing a random‐effects model, was used to pool the hazard ratio (HR) comparing outcomes of abstinent against non‐abstinent individuals with alcohol‐associated cirrhosis. Results We included 19 studies involving 18,833 people with alcohol‐associated cirrhosis. The prevalence of alcohol abstinence was 53.8% (CI: 44.6%–62.7%). Over a mean follow‐up duration of 48.6 months, individuals who continued to consume alcohol had significantly lower overall survival compared to those who were abstinent (HR: 0.611, 95% CI: 0.506–0.738). These findings remained consistent in sensitivity/subgroup analysis for the presence of decompensation, study design and studies that assessed abstinence throughout follow‐up. Alcohol abstinence was associated with a significantly lower risk of hepatic decompensation (HR: 0.612, 95% CI: 0.473–0.792). Conclusions Alcohol abstinence is associated with substantial improvement in overall survival in alcohol‐associated cirrhosis. However, only half of the individuals with known alcohol‐associated cirrhosis are abstinent.

pharmacology & pharmacy,gastroenterology & hepatology
Typing of Aeromonas strains from patients with diarrhoea and from drinking water.

A. Havelaar,F. M. Schets,A. van Silfhout,W. Jansen,G. Wieten,D. van der Kooij

DOI: https://doi.org/10.1111/J.1365-2672.1992.TB01857.X

1992-05-01

Journal of Applied Bacteriology

Abstract:Aeromonas strains (187) from human diarrhoeal stools and from drinking water (263) in The Netherlands were typed by three different methods. Biotyping alone was found to be of little value for epidemiological studies because 84% of all strains belonged to only 10 biotypes. Common biotypes could be further differentiated by serotyping. Gas-liquid chromatography of cell wall fatty acid methyl esters (FAME) was useful for species identification as well as for typing: 86% of all strains could be identified to the species level, and within this group 92% of all identifications corresponded with the biotype. Cluster analysis and principal component analysis of FAME profiles could be used for comparison of strains from different sources and gave the same general conclusions as bio- and serotyping. There was little overall similarity between Aeromonas strains from human (diarrhoeal) faeces and from drinking water, differences being most pronounced for Aeromonas caviae and least for A. sobria.
The Lower Survival in Patients With Alcoholism and Hepatitis C Continues in the DAA Era

Paul J Thuluvath,Waseem Amjad,Jose Russe-Russe,Feng Li,Paul J. Thuluvath

DOI: https://doi.org/10.1097/tp.0000000000004953

2024-02-23

Transplantation

Abstract:Background. Alcohol liver disease (ALD) may coexist with hepatitis C (HCV) in many transplant recipients (alcoholic cirrhosis with hepatitis C [AHC]). Our objective was to determine whether there were differences in postliver transplantation outcomes of patients with AHC when compared with those with alcoholic cirrhosis (AC) and/or alcoholic hepatitis (AH). Methods. Using UNOS explant data sets (2016–2020), the survival probabilities of AC, AH, and AHC were compared by Kaplan-Meier survival analysis. Cox proportional-hazard regression analysis was used to determine outcomes after adjusting for disease confounders. The outcomes were also compared with predirect antiviral agent (DAA) period. Results. During study period, 8369 biopsy-proven ALD liver transplant recipients were identified. Of those, 647 had AHC (HCV + alcohol), 353 had AH, and 7369 had AC. MELD-Na score (28.7 ± 9.5 versus 23.8 ± 10.7, P < 0.001) and presence of ACLF-3 (19% versus 11%, P < 0.001) were higher in AC + AH as compared with AHC. AHC and AC+AH has similar adjusted mortality at 1-y, but 3-y (hazard ratios, 1.76; 95% confidence intervals, 1.32-2.35; P < 0.0001) and 5-y (hazard ratios, 1.64; 95% confidence intervals, 1.24-2.15; P = 0.0004) mortality rates were higher in AHC. Survival improved in the DAA era (2016–2020) compared with 2009 to 2013 in AHC, but remained worse in AHC group versus AC and/or AH. Malignancy-related mortality was higher in AHC (15% versus 9.3% in AC) in the DAA era. Conclusions. AHC was associated with lower 3- and 5-y post-LT survival as compared with ALD without HCV and the worse outcomes in AHC group continued in the DAA era.

immunology,surgery,transplantation
[The sex-trapping of Sterrha biselata (Hufn.) (Lepidoptera Geometridae, Sterrhinae) by acetoxy-1 dodecadiens-7 E, 9Z, the sex pheromone of Lobesia botrana (Schiff.) (Lepidoptera Tortricidae, Olethreutinae)].

G. Biwer,B. Lalanne-Cassou,C. Descoins,D. Samain

1975-03-24

Abstract:7E, 9Z dodecadienyl acetate, a sex-heromone for Lobesia botrana, is selectively attractive, in vineyards, for males of this species. By testing this compound in woods and orchards, we have found that it was also selectively attractive for males of a geometrid moth; Sterrha biselata. This is one of the first examples where a definite chemical substance is active for a geometrid species.
Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis

Tomoo Yamazaki,Tetsuya Kouno,Cynthia L Hsu,Phillipp Hartmann,Susan Mayo,Xinlian Zhang,Peter Stärkel,Francisco Bosques-Padilla,Elizabeth C Verna,Juan G Abraldes,Robert S Brown,Victor Vargas,Jose Altamirano,Juan Caballería,Debbie L Shawcross,Alexandre Louvet,Michael R Lucey,Philippe Mathurin,Guadalupe Garcia-Tsao,Ramon Bataller,Bernd Schnabl,Cynthia L. Hsu,Elizabeth C. Verna,Juan G. Abraldes,Robert S. Brown,Debbie L. Shawcross,Michael R. Lucey,

DOI: https://doi.org/10.1097/hep.0000000000000777

IF: 17.298

2024-02-20

Hepatology

Abstract:Background: Patients with alcohol-associated hepatitis (AH) have an altered fecal metabolome, including reduced microbiota-derived tryptophan metabolites which function as ligands for aryl hydrocarbon receptor (AhR). The aim of this study was to assess serum AhR ligand activity in AH patients. Methods: The study included 74 controls without alcohol use disorder (AUD), 97 patients with AUD and 330 AH patients from two different multicenter cohorts (InTeam: 134, AlcHepNet: 196). Serum AhR activity was evaluated using an AhR reporter assay with HepG2-Lucia cells incubated with serum for 24 hours. Results: Serum AhR activity was significantly higher in patients with AH compared with both controls (1.59 vs. 0.96-fold change, p <0.001) and patients with AUD (1.59 vs. 0.93, p <0.001). In both AH cohorts, patients with AhR activity ≥ 2.09 had significantly lower cumulative survival rates at 30, 60, 90, and 180 days compared to those with AhR activity<2.09. When serum AhR activity was used to further stratify patients with severe AH, the cumulative 30, 60, 90, and 180-day survival rates for patients with severe AH and the AhR activity ≥ 2.09 group were all significantly lower than those with an AhR activity<2.09 group. Conclusion: Serum AhR activity was significantly higher in patients with AH compared with controls and individuals with AUD, and this increased activity was associated with higher mortality. Consequently, serum AhR activity holds potential as a prognostic marker.

gastroenterology & hepatology
Age added to MELD or ACLF predicts survival in patients with alcohol-associated hepatitis declined for liver transplantation

Stephanie M Rutledge,Rohit Nathani,Brooke E Wyatt,Erin Eschbach,Parth Trivedi,Stanley Kerznerman,Lily Chu,Thomas D Schiano,Leona Kim-Schluger,Sander Florman,Gene Y Im

DOI: https://doi.org/10.1097/HC9.0000000000000514

2024-08-19

Abstract:Background: Severe alcohol-associated hepatitis (AH) that is nonresponsive to corticosteroids is associated with high mortality, particularly with concomitant acute-on-chronic liver failure (ACLF). Most patients will not be candidates for liver transplantation (LT) and their outcomes are largely unknown. Our aim was to determine the outcomes of these declined candidates and to derive practical prediction models for transplant-free survival applicable at the time of the waitlist decision. Methods: We analyzed a database of patients with severe AH who were hospitalized at a LT center from January 2012 to July 2021, using the National Death Index for those lacking follow-up. Clinical variables were analyzed based on the endpoints of mortality at 30, 60, 90, and 180 days. Logistic and Cox regression analyses were used for model derivation. Results: Over 9.5 years, 206 patients with severe AH were declined for LT, mostly for unfavorable psychosocial profiles, with a mean MELD of 33 (±8), and 61% with ACLF. Over a median follow-up of 521 (17.5-1368) days, 58% (119/206) died at a median of 21 (9-124) days. Of 32 variables, only age added prognostic value to MELD and ACLF grade. CLIF-C ACLF score and 2 new models, MELD-Age and ACLF-Age, had similar predictability (AUROC: 0.73, 0.73, 0.72, respectively), outperforming Lille and Maddrey's (AUROC: 0.63, 0.62). In internal cross-validation, the average AUROC was 0.74. ACLF grade ≥2, MELD score >35, and age >45 years were useful cutoffs for predicting increased 90-day mortality from waitlist decision. Only two patients initially declined for LT for AH subsequently underwent LT (1%). Conclusions: Patients with severe AH declined for LT have high short-term mortality and rare rates of subsequent LT. Age added to MELD or ACLF grade enhances survival prediction at the time of waitlist decision in patients with severe AH declined for LT.
O-6 EXPLORING THE IMPACT OF INFECTIONS IN PATIENTS WITH ALCOHOL- ASSOCIATED HEPATITIS IN LATIN AMERICA

Luis Antonio Díaz,Francisco Idalsoaga,Gustavo Ayares,Jorge Arnold,Katherine Maldonado,María Ayala,Diego Perez,Jaime Gomez,Rodrigo Escarate,Eduardo Fuentes,Juan Pablo Roblero,Blanca Norero,Raul Lazarte,José Antonio Velarde,Janett Jacobo,Jacqueline Córdova,Fátima Higuera-de-la-Tijera,Jesús Varela,Scherezada Mejía,Rita Silva,Cristina Melo,Roberta C. Araujo,Gustavo Henrique Pereira,Claudia Couto,Fernando Bessone,Mario Tanno,Gustavo Romero,Manuel Mendizabal,Sebastián Marciano,Gonzalo Gomez,Melisa Dirchwolf,Pedro Montes,Patricia Guerra,Geraldine Ramos,Juan Carlos Restrepo,Enrique Carrera,Mayur Brahmania,Ashwani Singal,Ramón Bataller,Vijay Shah,Patrick S. Kamath,Marco Arrese,Juan Pablo Arab

DOI: https://doi.org/10.1016/j.aohep.2023.101256

IF: 3.388

2024-02-01

Annals of Hepatology

Abstract:Introduction and Methods Severe alcohol-associated hepatitis (AH) is frequently associated with higher infection risk. This study aimed to assess the impact of infections in patients with AH in a multinational cohort in Latin America. Materials and Methods Multicenter prospective cohort study including patients with AH (2015-2022). We recorded clinical information, and the impact of infections was assessed using competing-risk models. Results We included 511 patients from 24 centers in 8 countries (Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Mexico, and Peru). The mean age was 50.1±11.9 years, 426 (83.9%) were men, 264 (58.2%) had a previous diagnosis of cirrhosis, and the median MELD at diagnosis was 24.6 [19.6–30.6] points. Out of the total, 25.9% died, and only 3.7% underwent liver transplantation during follow-up. Also, 44.5% of patients developed an infection. Of them, 50.9% presented with infection at admission, 30.8% developed an infection during hospitalization, and 18.3% presented an infection in both situations. The most common localizations at admission were pulmonary (32.4%), urinary tract (33.1%), spontaneous bacterial peritonitis (15.9%), and cutaneous (9.7%). The main localizations during hospitalization were pulmonary (34.4%), urinary tract (25.8%), spontaneous bacterial peritonitis (14.0%), and bacteremia (8.6%%). The incidence of multidrug-resistant (MDR) organisms was 11.2% at admission and 10.3% during hospitalization, while the incidence of extensively drug-resistant (XDR) organisms was 1.4% and 4.7%, respectively. The presence of infection was associated with higher mortality (sub-distribution hazard ratio [sHR] 1.92, 95%CI:1.56–2.37; p<0.001). In a competing-risk model adjusted by age, sex, MELD, and ACLF grade, the infections were independently associated with mortality (sHR 1.33, 95%CI:1.02–1.75; p=0.037). Conclusions Infections during an AH episode are frequent and independently associated with mortality in Latin America. However, the incidence of multidrug-resistant organisms was lower than in other regions. Efforts should be made to prevent, diagnose, and adequately treat infections in AH.

gastroenterology & hepatology
Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis

Carolina Ramirez‐Cadiz,Hanna Blaney,Natalia Kubanek,Luis Antonio Díaz,Rohit Loomba,Lubomir Skladany,Juan Pablo Arab

DOI: https://doi.org/10.1111/apt.17948

IF: 9.524

2024-03-14

Alimentary Pharmacology & Therapeutics

Abstract:Summary Background Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject of debate. Aims To provide a narrative review of the natural history, diagnostic criteria and indications for referral for early liver transplantation for severe AH. Methods We searched PubMed for articles published through August 2023. Key search terms were 'alcoholic hepatitis,' 'alcohol‐associated hepatitis,' 'abstinence,' 'alcohol relapse,' and 'liver transplantation.' Results Previously, a six‐month period of alcohol abstinence was required before patients with ALD were considered for liver transplantation. However, studies in recent years have demonstrated that, among carefully selected patients, patients who received early transplants have much higher survival rates than patients with similarly severe disease who did not undergo transplants (77% vs. 23%). Despite these successes, early liver transplantation remains controversial, as these patients have typically not undergone treatment for alcohol use disorder, with the ensuing risk of returning to alcohol use. Conclusions While early liver transplantation for AH has survival benefits, many patients would not have received treatment for alcohol use disorder. An integrated approach to evaluating candidacy for early liver transplantation is needed.

pharmacology & pharmacy,gastroenterology & hepatology
S2091 Outcomes of Alcohol-Associated Hepatitis in Hospitalized Patients With Prior Bariatric Surgery: A Nationwide Analysis, 2016-2020

Sarpong Boateng,Prince A. Ameyaw,Karthik Mathialagan,William KB. Boateng,Basile Njei

DOI: https://doi.org/10.14309/01.ajg.0001037732.36409.47

2024-10-26

The American Journal of Gastroenterology

Abstract:Alcohol-associated hepatitis (AAH) is a severe liver condition often necessitating hospitalization and has a 1-year mortality of 40%. The increasing prevalence of obesity has led to a rise in bariatric surgery (BS), which can alter the outcomes of various comorbid conditions. There are some concerns about possible increased risk and severity of alcohol related disorders in patients with a history of BS due to alteration in alcohol metabolism after surgery. This study aims to evaluate the impact of prior BS on the outcomes of hospitalized patients with AAH in the United States.

gastroenterology & hepatology
Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissions

Asim Kichloo,Zain El-Amir,Dushyant Singh Dahiya,Farah Wani,Jagmeet Singh,Dhanshree Solanki,Ehizogie Edigin,Precious Eseaton,Asad Mehboob,Hafeez Shaka

DOI: https://doi.org/10.4254/wjh.v13.i12.2128

2021-12-27

Abstract:Background: Alcoholic liver cirrhosis (ALC) is a chronic liver disease with varying disease severity. Readmissions of ALC are associated with poor outcomes. Aim: To identify and assess trends of readmissions for ALC over an eight-year period. Methods: This retrospective interrupted trend study analysed 30-d readmissions of ALC in the United States from 2010 to 2018 using the National Readmissions Database. Hospitalization for ALC was the reason for index admission obtained using the International Classification of Diseases codes (571.2 and K70.3X). Biodemographic characteristics and hospitalization trends were highlighted over time. A multivariate regression analysis model was used to calculate the trend for risk-adjusted odds of 30-d all-cause ALC readmissions, ALC specific readmission rate, ALC readmission proportion, inpatient mortality, mean length of stay (LOS) and mean total hospital cost (THC) following adjustments for age, gender, grouped Charlson Comorbidity Index, insurance, mean household income, and hospital characteristics. Results: There was a trend towards increasing total 30-d readmissions of ALC from 7660 in 2010 to 15085 in 2018 (P < 0.001). Patients readmitted for ALC were noted to have an increasing comorbidity burden over time. We noted a rise in the risk-adjusted 30-d all-cause readmission of ALC from 24.9% in 2010 to 29.9% in 2018 (P < 0.001). ALC-specific readmission rate increased from 6.3% in 2010 to 8.4% in 2018 (P < 0.001) while ALC readmission proportion increased from 31.4% in 2010 to 36.3% in 2018 (P < 0.001). Inpatient mortality for 30-d readmissions of ALC declined from 10.5% in 2010 to 8.2% in 2018 (P = 0.0079). However, there was a trend towards increasing LOS from 5.6 d in 2010 to 6.3 d in 2018 (P < 0.001) and increasing THC from 13790 dollars in 2010 to 17150 dollars in 2018 (P < 0.001). The total days of hospital stay attributable to 30-d readmissions of ALC increased by 119.2% while the total attributable hospital costs increased by 149% by the end of 2018. Conclusion: There was an increase in the 30-d readmission rate and comorbidity burden for ALC; however, inpatient mortality declined. Additionally, there was a trend towards increasing LOS and THC for these readmissions.

[Characteristics of liver damage in children with mucoviscidosis].

Recurrent alcohol-associated hepatitis is common and is associated with increased mortality

[Internet application for medical purposes in chronic patients cared in a systemic autoimmune diseases unit].

Trauma is a recurrent disease.

P-19 CHARACTERIZATION, PROGNOSTIC FACTORS, AND SURVIVAL IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS: A MULTICENTER STUDY

The Survival Benefit of Re-abstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multi-Center ACCELERATE Study

Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium

Declining Inpatient Mortality Despite Increasing Thirty-Day Readmissions of Alcoholic Hepatitis in the United States From 2010 to 2018

Emerging Pharmacotherapies in Alcohol-Associated Hepatitis

Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis

Racial Disparities in Alcoholic Hepatitis Hospitalizations in the United States: Trends, Outcomes, and Future Projections

Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis: Systematic review and meta‐analysis

Typing of Aeromonas strains from patients with diarrhoea and from drinking water.

The Lower Survival in Patients With Alcoholism and Hepatitis C Continues in the DAA Era

[The sex-trapping of Sterrha biselata (Hufn.) (Lepidoptera Geometridae, Sterrhinae) by acetoxy-1 dodecadiens-7 E, 9Z, the sex pheromone of Lobesia botrana (Schiff.) (Lepidoptera Tortricidae, Olethreutinae)].

Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis

Age added to MELD or ACLF predicts survival in patients with alcohol-associated hepatitis declined for liver transplantation

O-6 EXPLORING THE IMPACT OF INFECTIONS IN PATIENTS WITH ALCOHOL- ASSOCIATED HEPATITIS IN LATIN AMERICA

Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis

S2091 Outcomes of Alcohol-Associated Hepatitis in Hospitalized Patients With Prior Bariatric Surgery: A Nationwide Analysis, 2016-2020

Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissions